<p>Oscar Health, Inc.（紐約證券交易所代碼：OSCR - 獲取免費報告）在週四的午盤交易中下跌了 7.9%，原因是巴克萊將該股票的目標價從 17.00 美元下調至 11.00 美元。巴克萊目前對該股票的評級為減持。Oscar Health 的股價最低曾達到 14.65 美元，最後交易價為 14.62 美元。在交易過程中，約有 20,708,746 股成交，較平均每日成交量 12,433,063 股增加了 67%。該股票此前收盤價為 15.87 美元。</p>
<ul>
<li>5 只具有爆炸性上漲潛力的小型股</li>
</ul>
<p>其他一些研究分析師也最近對 OSCR 發表了評論。富國銀行將 Oscar Health 的評級從 “持平” 下調至 “減持”，並在 7 月 11 日的研究報告中將該公司的目標價從 16.00 美元下調至 10.00 美元。派珀·桑德勒將 Oscar Health 的評級從 “增持” 下調至 “中性”，並在 7 月 14 日的研究報告中設定了 14.00 美元的目標價。華爾街 Zen 在 6 月 8 日的研究報告中將 Oscar Health 的評級從 “買入” 下調至 “持有”。瑞銀集團在 7 月 15 日的研究報告中重申了 “賣出” 評級，並將 Oscar Health 的目標價下調至 11.00 美元（之前為 15.00 美元）。最後，雷蒙德·詹姆斯金融在 6 月 24 日的研究報告中將 Oscar Health 的評級從 “跑贏大盤” 下調至 “市場表現”。五位研究分析師對該股票給予了 “賣出” 評級，三位分析師給予了 “持有” 評級。根據 MarketBeat 的數據，Oscar Health 目前的共識評級為 “減持”，平均目標價為 11.92 美元。</p>
<p><strong>閲讀我們關於 Oscar Health 的最新股票報告</strong></p>
<h2>內部買賣</h2>
<p>在相關消息中，董事 Elbert O. Jr. Robinson 在 5 月 12 日的交易中出售了 25,000 股公司的股票。該股票以平均價格 16.43 美元出售，總價值為 410,750.00 美元。出售後，該董事直接持有公司 64,512 股股票，價值為 1,059,932.16 美元。這代表其持股比例減少了 27.93%。該出售在與 SEC 的法律文件中披露，文件可通過此鏈接獲取。24.39% 的股票由內部人士持有。</p>
<h2>對 Oscar Health 的對沖基金看法</h2>
<p>一些機構投資者和對沖基金最近修改了對該公司的持股。滙豐控股在第一季度將其在 Oscar Health 的持股比例提高了 2.7%。滙豐控股目前擁有 24,113 股公司股票，價值為 313,000 美元，此前在該期間購買了 632 股。Tempus Wealth Planning LLC 在第一季度將其在 Oscar Health 的持股比例提高了 6.7%。Tempus Wealth Planning LLC 目前擁有 14,392 股公司股票，價值為 189,000 美元，此前在上個季度購買了 906 股。Focus Partners Wealth 在第一季度將其在 Oscar Health 的持股比例提高了 1.8%。Focus Partners Wealth 目前擁有 55,158 股公司股票，價值為 723,000 美元，此前在上個季度購買了 949 股。Xponance Inc.在第一季度將其在 Oscar Health 的持股比例提高了 7.1%。Xponance Inc.目前擁有 15,423 股公司股票，價值為 202,000 美元，此前在上個季度購買了 1,029 股。最後，CWM LLC 在第一季度將其在 Oscar Health 的持股比例提高了 50.7%。CWM LLC 目前擁有 3,204 股公司股票，價值為 42,000 美元，此前在上個季度購買了 1,078 股。當前 75.70% 的股票由機構投資者持有。</p>
<h2>Oscar Health 的價格表現</h2>
<p>該公司的市值為 37.3 億美元，市盈率為 52.20，貝塔值為 1.90。該公司的 50 日移動平均線為 16.10 美元，200 日移動平均線為 14.92 美元。公司的流動比率為 0.88，速動比率為 0.88，債務與股本比率為 0.22。</p>
<p>Oscar Health（紐約證券交易所代碼：OSCR - 獲取免費報告）最後一次公佈財報是在 5 月 7 日，報告顯示該公司季度每股收益（EPS）為 0.92 美元，超出市場共識預期的 0.83 美元，超出幅度為 0.09 美元。Oscar Health 的股本回報率為 10.59%，淨利潤率為 1.22%。該公司在該季度的收入為 30 億美元，而分析師預期為 28.7 億美元。去年同期，該公司每股收益為 0.62 美元。與去年同期相比，該公司的收入增長了 42.2%。整體來看，研究分析師預計 Oscar Health, Inc.在當前財政年度將發佈 0.69 美元的每股收益。</p>
<h2>關於 Oscar Health</h2>
<p>（獲取免費報告）</p>
<p>Oscar Health, Inc.在美國運營作為一家健康保險公司。該公司在個人和小型團體市場提供健康計劃，以及 +Oscar，一個技術驅動的平台，幫助提供者和支付方直接實現向基於價值的護理轉型。它還提供再保險產品。</p>
<h2>推薦故事</h2>
<ul>
<li>五隻我們更看好的股票超過 Oscar Health</li>
<li>3 只股票引領了迷因股的復甦</li>
<li>為什麼期權交易者對 Oracle 股票押注很大</li>
<li>消費者可選消費股票解析</li>
<li>Alphabet 的突破性季度預示着新的領導階段</li>
<li>ETF 是否支付股息？你需要知道的事項</li>
<li>Rivian 股票在機器人出租車熱潮中上漲</li>
</ul>
<p><em>此即時新聞提醒由敍述科學技術和 MarketBeat 的金融數據生成，以便為讀者提供最快和最準確的報道。此故事在發佈前已由 MarketBeat 的編輯團隊審核。如對該故事有任何問題或意見，請發送電子郵件至 contact@marketbeat.com。</em></p>
<h2>你現在應該投資 1,000 美元在 Oscar Health 嗎？</h2>
<p>在考慮 Oscar Health 之前，你需要聽聽這個。</p>
<p>MarketBeat 每天跟蹤華爾街評級最高和表現最佳的研究分析師及他們推薦給客户的股票。MarketBeat 已經識別出五隻股票，頂級分析師正在悄悄地向他們的客户推薦現在購買，以便在更廣泛的市場注意到之前……而 Oscar Health 並不在名單上。</p>
<p>雖然 Oscar Health 目前在分析師中被評為強烈賣出，但頂級分析師認為這五隻股票更值得購買。</p>
<p>在這裏查看這五隻股票</p>

OSCR

<p>奧斯卡健康（NYSE:OSCR）股價下跌 7.9%，因巴克萊將其目標價從 17.00 美元下調至 11.00 美元，並維持了減持評級。該股最低交易價為 14.65 美元，交易量顯著增加。包括富國銀行和派珀·桑德勒在內的其他分析師也下調了該股評級，導致市場共識評級為 “減持”，平均目標價為 11.92 美元。內部交易活動顯示一名董事出售了 25,000 股，持股比例減少了 27.93%。奧斯卡健康在最新的財報中報告了 42.2% 的年同比收入增長</p>

<p>Oscar Health, Inc. (NYSE:OSCR - Get Free Report) dropped 7.9% during mid-day trading on Thursday after Barclays lowered their price target on the stock from $17.00 to $11.00. Barclays currently has an underweight rating on the stock. Oscar Health traded as low as $14.65 and last traded at $14.62. Approximately 20,708,746 shares changed hands during trading, an increase of 67% from the average daily volume of 12,433,063 shares. The stock had previously closed at $15.87.</p>
<div class="lb-trans"><p>Oscar Health, Inc.（紐約證券交易所代碼：OSCR - 獲取免費報告）在週四的午盤交易中下跌了 7.9%，原因是巴克萊將該股票的目標價從 17.00 美元下調至 11.00 美元。巴克萊目前對該股票的評級為減持。Oscar Health 的股價最低曾達到 14.65 美元，最後交易價為 14.62 美元。在交易過程中，約有 20,708,746 股成交，較平均每日成交量 12,433,063 股增加了 67%。該股票此前收盤價為 15.87 美元。</p>
</div><ul>
<li>5 Small Cap Stocks With Explosive Upside Potential</li>
</ul>
<div class="lb-trans"><ul>
<li>5 只具有爆炸性上漲潛力的小型股</li>
</ul>
</div><p>A number of other research analysts also recently commented on OSCR. Wells Fargo &amp; Company downgraded Oscar Health from an &#34;equal weight&#34; rating to an &#34;underweight&#34; rating and dropped their price target for the company from $16.00 to $10.00 in a research note on Friday, July 11th. Piper Sandler downgraded Oscar Health from an &#34;overweight&#34; rating to a &#34;neutral&#34; rating and set a $14.00 price target for the company. in a research note on Monday, July 14th. Wall Street Zen downgraded Oscar Health from a &#34;buy&#34; rating to a &#34;hold&#34; rating in a research note on Sunday, June 8th. UBS Group restated a &#34;sell&#34; rating and issued a $11.00 target price (down previously from $15.00) on shares of Oscar Health in a research report on Tuesday, July 15th. Finally, Raymond James Financial lowered shares of Oscar Health from an &#34;outperform&#34; rating to a &#34;market perform&#34; rating in a research report on Tuesday, June 24th. Five research analysts have rated the stock with a sell rating and three have issued a hold rating to the company's stock. Based on data from MarketBeat, Oscar Health presently has a consensus rating of &#34;Reduce&#34; and an average price target of $11.92.</p>
<div class="lb-trans"><p>其他一些研究分析師也最近對 OSCR 發表了評論。富國銀行將 Oscar Health 的評級從 “持平” 下調至 “減持”，並在 7 月 11 日的研究報告中將該公司的目標價從 16.00 美元下調至 10.00 美元。派珀·桑德勒將 Oscar Health 的評級從 “增持” 下調至 “中性”，並在 7 月 14 日的研究報告中設定了 14.00 美元的目標價。華爾街 Zen 在 6 月 8 日的研究報告中將 Oscar Health 的評級從 “買入” 下調至 “持有”。瑞銀集團在 7 月 15 日的研究報告中重申了 “賣出” 評級，並將 Oscar Health 的目標價下調至 11.00 美元（之前為 15.00 美元）。最後，雷蒙德·詹姆斯金融在 6 月 24 日的研究報告中將 Oscar Health 的評級從 “跑贏大盤” 下調至 “市場表現”。五位研究分析師對該股票給予了 “賣出” 評級，三位分析師給予了 “持有” 評級。根據 MarketBeat 的數據，Oscar Health 目前的共識評級為 “減持”，平均目標價為 11.92 美元。</p>
</div><p><strong>Read Our Latest Stock Report on Oscar Health</strong></p>
<div class="lb-trans"><p><strong>閲讀我們關於 Oscar Health 的最新股票報告</strong></p>
</div><h2>Insider Buying and Selling</h2>
<div class="lb-trans"><h2>內部買賣</h2>
</div><p>In related news, Director Elbert O. Jr. Robinson sold 25,000 shares of the company's stock in a transaction that occurred on Monday, May 12th. The stock was sold at an average price of $16.43, for a total value of $410,750.00. Following the sale, the director directly owned 64,512 shares in the company, valued at $1,059,932.16. This represents a 27.93% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. 24.39% of the stock is owned by insiders.</p>
<div class="lb-trans"><p>在相關消息中，董事 Elbert O. Jr. Robinson 在 5 月 12 日的交易中出售了 25,000 股公司的股票。該股票以平均價格 16.43 美元出售，總價值為 410,750.00 美元。出售後，該董事直接持有公司 64,512 股股票，價值為 1,059,932.16 美元。這代表其持股比例減少了 27.93%。該出售在與 SEC 的法律文件中披露，文件可通過此鏈接獲取。24.39% 的股票由內部人士持有。</p>
</div><h2>Hedge Funds Weigh In On Oscar Health</h2>
<div class="lb-trans"><h2>對 Oscar Health 的對沖基金看法</h2>
</div><p>A number of institutional investors and hedge funds have recently modified their holdings of the business. Hsbc Holdings PLC raised its position in shares of Oscar Health by 2.7% during the first quarter. Hsbc Holdings PLC now owns 24,113 shares of the company's stock worth $313,000 after purchasing an additional 632 shares during the period. Tempus Wealth Planning LLC raised its position in Oscar Health by 6.7% in the 1st quarter. Tempus Wealth Planning LLC now owns 14,392 shares of the company's stock valued at $189,000 after buying an additional 906 shares during the last quarter. Focus Partners Wealth raised its position in Oscar Health by 1.8% in the 1st quarter. Focus Partners Wealth now owns 55,158 shares of the company's stock valued at $723,000 after buying an additional 949 shares during the last quarter. Xponance Inc. raised its position in Oscar Health by 7.1% in the 1st quarter. Xponance Inc. now owns 15,423 shares of the company's stock valued at $202,000 after buying an additional 1,029 shares during the last quarter. Finally, CWM LLC raised its position in Oscar Health by 50.7% in the 1st quarter. CWM LLC now owns 3,204 shares of the company's stock valued at $42,000 after buying an additional 1,078 shares during the last quarter. 75.70% of the stock is currently owned by institutional investors.</p>
<div class="lb-trans"><p>一些機構投資者和對沖基金最近修改了對該公司的持股。滙豐控股在第一季度將其在 Oscar Health 的持股比例提高了 2.7%。滙豐控股目前擁有 24,113 股公司股票，價值為 313,000 美元，此前在該期間購買了 632 股。Tempus Wealth Planning LLC 在第一季度將其在 Oscar Health 的持股比例提高了 6.7%。Tempus Wealth Planning LLC 目前擁有 14,392 股公司股票，價值為 189,000 美元，此前在上個季度購買了 906 股。Focus Partners Wealth 在第一季度將其在 Oscar Health 的持股比例提高了 1.8%。Focus Partners Wealth 目前擁有 55,158 股公司股票，價值為 723,000 美元，此前在上個季度購買了 949 股。Xponance Inc.在第一季度將其在 Oscar Health 的持股比例提高了 7.1%。Xponance Inc.目前擁有 15,423 股公司股票，價值為 202,000 美元，此前在上個季度購買了 1,029 股。最後，CWM LLC 在第一季度將其在 Oscar Health 的持股比例提高了 50.7%。CWM LLC 目前擁有 3,204 股公司股票，價值為 42,000 美元，此前在上個季度購買了 1,078 股。當前 75.70% 的股票由機構投資者持有。</p>
</div><h2>Oscar Health Price Performance</h2>
<div class="lb-trans"><h2>Oscar Health 的價格表現</h2>
</div><p>The firm has a market capitalization of $3.73 billion, a PE ratio of 52.20 and a beta of 1.90. The business has a 50-day moving average of $16.10 and a 200 day moving average of $14.92. The company has a current ratio of 0.88, a quick ratio of 0.88 and a debt-to-equity ratio of 0.22.</p>
<div class="lb-trans"><p>該公司的市值為 37.3 億美元，市盈率為 52.20，貝塔值為 1.90。該公司的 50 日移動平均線為 16.10 美元，200 日移動平均線為 14.92 美元。公司的流動比率為 0.88，速動比率為 0.88，債務與股本比率為 0.22。</p>
</div><p>Oscar Health (NYSE:OSCR - Get Free Report) last announced its earnings results on Wednesday, May 7th. The company reported $0.92 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.83 by $0.09. Oscar Health had a return on equity of 10.59% and a net margin of 1.22%. The firm had revenue of $3 billion during the quarter, compared to analyst estimates of $2.87 billion. During the same period last year, the firm posted $0.62 EPS. The business's revenue was up 42.2% compared to the same quarter last year. As a group, research analysts anticipate that Oscar Health, Inc. will post 0.69 EPS for the current fiscal year.</p>
<div class="lb-trans"><p>Oscar Health（紐約證券交易所代碼：OSCR - 獲取免費報告）最後一次公佈財報是在 5 月 7 日，報告顯示該公司季度每股收益（EPS）為 0.92 美元，超出市場共識預期的 0.83 美元，超出幅度為 0.09 美元。Oscar Health 的股本回報率為 10.59%，淨利潤率為 1.22%。該公司在該季度的收入為 30 億美元，而分析師預期為 28.7 億美元。去年同期，該公司每股收益為 0.62 美元。與去年同期相比，該公司的收入增長了 42.2%。整體來看，研究分析師預計 Oscar Health, Inc.在當前財政年度將發佈 0.69 美元的每股收益。</p>
</div><h2>About Oscar Health</h2>
<div class="lb-trans"><h2>關於 Oscar Health</h2>
</div><p>(Get Free Report)</p>
<div class="lb-trans"><p>（獲取免費報告）</p>
</div><p>Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.</p>
<div class="lb-trans"><p>Oscar Health, Inc.在美國運營作為一家健康保險公司。該公司在個人和小型團體市場提供健康計劃，以及 +Oscar，一個技術驅動的平台，幫助提供者和支付方直接實現向基於價值的護理轉型。它還提供再保險產品。</p>
</div><h2>Recommended Stories</h2>
<div class="lb-trans"><h2>推薦故事</h2>
</div><ul>
<li>Five stocks we like better than Oscar Health</li>
<li>3 Tickers Leading a Meme Stock Revival</li>
<li>Why Options Traders Are Betting Big on Oracle Stock</li>
<li>Consumer Discretionary Stocks Explained</li>
<li>Alphabet’s Breakout Quarter Signals a New Leadership Phase</li>
<li>Do ETFs Pay Dividends? What You Need to Know</li>
<li>Rivian Stock Rallies as Robotaxi Buzz Builds</li>
</ul>
<div class="lb-trans"><ul>
<li>五隻我們更看好的股票超過 Oscar Health</li>
<li>3 只股票引領了迷因股的復甦</li>
<li>為什麼期權交易者對 Oracle 股票押注很大</li>
<li>消費者可選消費股票解析</li>
<li>Alphabet 的突破性季度預示着新的領導階段</li>
<li>ETF 是否支付股息？你需要知道的事項</li>
<li>Rivian 股票在機器人出租車熱潮中上漲</li>
</ul>
</div><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即時新聞提醒由敍述科學技術和 MarketBeat 的金融數據生成，以便為讀者提供最快和最準確的報道。此故事在發佈前已由 MarketBeat 的編輯團隊審核。如對該故事有任何問題或意見，請發送電子郵件至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in Oscar Health Right Now?</h2>
<div class="lb-trans"><h2>你現在應該投資 1,000 美元在 Oscar Health 嗎？</h2>
</div><p>Before you consider Oscar Health, you'll want to hear this.</p>
<div class="lb-trans"><p>在考慮 Oscar Health 之前，你需要聽聽這個。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Oscar Health wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟蹤華爾街評級最高和表現最佳的研究分析師及他們推薦給客户的股票。MarketBeat 已經識別出五隻股票，頂級分析師正在悄悄地向他們的客户推薦現在購買，以便在更廣泛的市場注意到之前……而 Oscar Health 並不在名單上。</p>
</div><p>While Oscar Health currently has a Strong Sell rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>雖然 Oscar Health 目前在分析師中被評為強烈賣出，但頂級分析師認為這五隻股票更值得購買。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在這裏查看這五隻股票</p>
</div>

Oscar Health (NYSE:OSCR) 的股價在分析師下調評級後下跌了 7.9%